The Flexibility of Compliance and What If …? Part 2/2 - 梅特勒-托利多
线上
研讨会
已安排的线上活动

The Flexibility of Compliance and What If …? Part 2/2

线上
研讨会
已安排的线上活动

Handling Risks and Errors in Pharma Records

Bob McDowall, experienced auditor, consultant and author of many books and papers around Electronic Records and Data Integrity Compliance for Pharmaceutical Industries.
Bob McDowall, experienced auditor, consultant and author of many books and papers around Electronic Records and Data Integrity Compliance for Pharmaceutical Industries.

Handling Risks and Errors in Pharma Records - there should be procedures to stay compliant. With their focus on Data Integrity, regulation authorities are ever pushing the pharmaceutical industries towards electronic records. The number of FDA warning letters with citations of data integrity violations reveal that not every pharma company interprets the rules correctly and with an acceptable risk management policy.

Conservative practices might overlook the dynamic of regulations and might end in incompliance just because the interpretation of rules have evolved.

Cost of webinar: the participation is free of charge.

To learn more about the ways to interpret Pharma Regulations.

Bob McDowall and Christoph Jansen
ca. 50 minutes
Fri Nov 26 2021 08:00 +0000 [ English ]
Fri Nov 26 2021 16:00 +0000 [ English ]

In this Webinar we will discuss with Bob McDowall:

Part 2/2

  • What are the action items of violations and findings?
  • Unofficial testing
  • What do you recommend in terms of software updates?
  • What is the best time to report issues?
  • Cost of compliance
  • Cost efficient CSV with platform solutions
 

Cost of webinar: the participation is free of charge.



此网页未针对您的web浏览器进行优化。请使用不同浏览器或升级浏览器到最新版本,以确保最好的体验。